Considerations for Late stage Customisation
With multiple member states, languages and country- specific pack formats, the European market is one of the most challenging markets to launch a product into. With each member state requiring labelling and packaging of a drug product to be in their official language, this requires generation of artwork and pack design, together with management of all packaging components.
Designing and manufacturing packaging for each of the member states can be costly. By streamlining operations and using a process called Late Stage Customisation you can significantly reduce costs to ensure a more efficient, flexible supply chain.
Click the button below to view the full article.
Almac Pharma Services provide a wide range of customised commercial services from supporting product launch, manufacturing and / or packaging drug product, to securing supply chain with global serialisation solutions.
Our flexible, quality-led commercial solutions range from orphan drug launches to ongoing high-volume commercial product manufacture, packaging and supply.